TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...
In a new nonfiction book, the Y.A. novelist describes the disease as a window into “the folly and brilliance and cruelty and ...
Tuberculosis (TB) remains a global health challenge, affecting millions each year. Globally, an estimated 10.8 million people ...
4dOpinion
More than half the TB patients in India seek private medical care. The current system of treatment of TB is confined to ...
In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory ...
The treatment of TB involves a combination of several antibiotics. These are aimed at reducing the risk of transmission, ...
Tuberculosis is the leading infectious cause of death around the world, outpaced only by COVID-19 during the first three ...
Even if US foreign aid cuts are reversed, the damage to global TB control has already been done, says Saw Swee Hock School of ...
Know about top innovations that will be part of the national TB elimination programme, help in screening and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback